$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Aberdeen Group plc Has $118.81 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
03:09am, Friday, 03'rd Apr 2026
Aberdeen Group plc lowered its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 16.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exc
Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note
07:01pm, Thursday, 02'nd Apr 2026
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $438.75, moving 1.9% from the previous trading session.
Vertex Pharmaceuticals: Label Expansions For ALYFTREK And TRIKAFTA Plus Strong Demand
02:13pm, Thursday, 02'nd Apr 2026
Vertex Pharmaceuticals (VRTX) remains a "Strong Buy", driven by robust CF franchise growth and successful label expansions for ALYFTREK and TRIKAFTA. VRTX's new label expansions now cover 95% of U.S.
F&V Capital Management LLC Buys Shares of 3,645 Vertex Pharmaceuticals Incorporated $VRTX
05:40am, Thursday, 02'nd Apr 2026
F&V Capital Management LLC bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) during the undefined quarter, according to the company in its most recent 13F filing with the Securi
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/
Boston Common Asset Management LLC Sells 20,952 Shares of Vertex Pharmaceuticals Incorporated $VRTX
05:00am, Tuesday, 31'st Mar 2026
Boston Common Asset Management LLC trimmed its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 51.2% during the undefined quarter, according to the company in its most rece
Beacon Investment Advisory Services Inc. Sells 2,049 Shares of Vertex Pharmaceuticals Incorporated $VRTX
03:34am, Monday, 30'th Mar 2026
Beacon Investment Advisory Services Inc. decreased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 2.7% during the fourth quarter, according to its most recent filing w
Prediction: The Trump Bull Market Is About to End -- but These Stocks Will Rise Anyway
03:45am, Saturday, 28'th Mar 2026
Multiple headwinds could bring the bull market to a halt. Stocks positioned to rise even during a market downturn include Berkshire Hathaway, Enbridge, and Vertex Pharmaceuticals.
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Congress Asset Management Co.
04:30am, Friday, 27'th Mar 2026
Congress Asset Management Co. trimmed its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 99.4% in the fourth quarter, according to its most recent disclosure with the SEC. The fund
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Given Consensus Rating of “Moderate Buy” by Analysts
02:37am, Friday, 27'th Mar 2026
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the twenty-nine brokerages that are covering the company, Marke
Vertex Pharmaceuticals (VRTX) Laps the Stock Market: Here's Why
06:51pm, Wednesday, 25'th Mar 2026
Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $454.97, signifying a +1.42% move from its prior day's close.
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 24'th Mar 2026
Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.
Gradient Investments LLC Has $19.76 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
06:27am, Monday, 23'rd Mar 2026
Gradient Investments LLC boosted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 6.4% in the fourth quarter, according to the company in its most recent Form 13F filing wi
Nordea Investment Management AB Has $202.61 Million Position in Vertex Pharmaceuticals Incorporated $VRTX
05:49am, Monday, 23'rd Mar 2026
Nordea Investment Management AB boosted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 23.8% in the fourth quarter, according to its most recent filing with the SEC. T
Grove Bank & Trust Boosts Holdings in Vertex Pharmaceuticals Incorporated $VRTX
05:34am, Sunday, 22'nd Mar 2026
Grove Bank and Trust increased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 374.7% during the undefined quarter, according to the company in its most recent 13F fili
Sign In
Buy VRTX